Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon vs butorphanol for patient-controlled analgesia after laparoscopic surgery
ChiCTR2600126220Phase 4Not yet recruiting
- Sponsor
- Wuhan Central Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hsk21542 in postoperative pain (2 arms), sponsored by Wuhan Central Hospital. Primary endpoint: Time-weighted pain intensity difference (SPID) 0–48 h. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600126220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126220.